Early Enoxaparin Treatment in a Newborn with Cerebral Venous Sinus Thrombosis and Acute Cerebellar Hemorrhage
Management of CSVT in neonates remains debated. While heparin may carry a risk of bleeding, delaying treatment can lead to thrombus progression. Our case supports the potential safety and efficacy of early heparin use in selected patients. Tailored, risk-based decisions may improve outcomes, though further studies are needed to establish standardized protocols.
Authors
- Domenico Marco Romeo (ORCID: https://orcid.org/0000-0002-6229-1208)
- Mirta Corsello
- Margherita Velardi (ORCID: https://orcid.org/0009-0001-4656-6056)
- Rita Luciano (ORCID: https://orcid.org/0000-0003-4358-0757)
- Tommaso Verdolotti (ORCID: https://orcid.org/0000-0001-8094-2847)
- Luca Massimi (ORCID: https://orcid.org/0000-0003-3088-0822)
- Simonetta Costa (ORCID: https://orcid.org/0000-0003-0980-5297)
- Francesca Gallini
- Giovanni Vento
Institutions
- Agostino Gemelli University Polyclinic (IT)
- Bambino Gesù Children's Hospital (IT)
- University of the Sacred Heart (JP)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- American Journal of Perinatology Reports
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1055/a-2566-3952
- Primary Topic
- Cerebral Venous Sinus Thrombosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00